+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Colorectal Cancer Drugs Market Report 2025 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-hodgkin Lymphoma (NHL) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 190 Pages
  • Global
From
T-cell Lymphoma Market 2024-2028 - Product Thumbnail Image

T-cell Lymphoma Market 2024-2028

  • Report
  • August 2024
  • 135 Pages
  • Global
From
From
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
Prostate Cancer Drugs Market Report 2025 - Product Thumbnail Image

Prostate Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator